TREATMENT INTENSIFICATION WITH NOVEL ANTIDIABETIC AGENTS INFLUENCES PLATELET REACTIVITY AND FUNCTIONALITY PARAMETERS IN MALE PATIENTS WITH TYPE 2 DIABETES

Evanthia Bletsa,Gerasimos Siasos,Panagiota K. Stampouloglou, Evangelos Oikonomou,Alexis S. Antonopoulos,Nikolaos Gouliopoulos,Vasiliki Tsigkou,Konstantinos Mourouzis,Marina Zaromytidou,Konstantinos Batzias,Stavroula Paschou,Andromachi Vryonidou,Athanasia Thanopoulou,Nikolaos Tentolouris,Dimitris Tousoulis

Journal of the American College of Cardiology（2020）

引用 0|浏览29

暂无评分

摘要

Patients with type 2 diabetes (T2D) are at high risk for thrombotic events. Platelet reactivity may be used to assess prothrombotic status. We investigated whether administration of novel antidiabetic agents may alter platelet reactivity in patients with T2D. We enrolled 54 consecutive male

查看译文

关键词

platelet reactivity,novel antidiabetic agents,diabetes,treatment intensification

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要